Location History:
- Basel, CH (2003 - 2005)
- Basle, CH (2005)
- Onex-Geneve, CH (2008)
Company Filing History:
Years Active: 2003-2008
Title: Sonia Maria Poli: Innovator in Pharmaceutical Chemistry
Introduction
Sonia Maria Poli is a distinguished inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. Her work focuses on developing compounds that address various neurological and psychiatric disorders.
Latest Patents
Among her latest patents is a compound known as 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide. This invention is particularly noteworthy for its potential applications in treating or preventing Alzheimer's disease, Parkinson's disease, Huntington's disease, and other conditions such as schizophrenia, anxiety, and depression. Additionally, she has developed D-proline prodrugs, which are beneficial in treating diseases where Serum Amyloid P Component depletion is advantageous, especially in central and systemic amyloidosis.
Career Highlights
Sonia is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her innovative work has positioned her as a key figure in the development of new therapeutic agents.
Collaborations
Throughout her career, Sonia has collaborated with notable colleagues, including Torsten Hoffmann and Patrick Schnider. These partnerships have further enhanced her research and development efforts.
Conclusion
Sonia Maria Poli's contributions to pharmaceutical chemistry are significant, with her inventions paving the way for new treatments for various neurological disorders. Her dedication to innovation continues to impact the field positively.